V. Cohen

645 total citations
32 papers, 491 citations indexed

About

V. Cohen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, V. Cohen has authored 32 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in V. Cohen's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (6 papers). V. Cohen is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (6 papers). V. Cohen collaborates with scholars based in Canada, United States and Australia. V. Cohen's co-authors include Jason Agulnik, Goulnar Kasymjanova, David Small, Carmela Pepe, Lama Sakr, M A Fletcher, Kevin Maher, Rafael Valenzuela, Nancy G. Klimas and Jason W. Triplett and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Urology.

In The Last Decade

V. Cohen

31 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Cohen Canada 12 216 214 124 98 64 32 491
K Moeremans Belgium 11 154 0.7× 84 0.4× 28 0.2× 50 0.5× 41 0.6× 36 386
Steve Shiboski United States 9 45 0.2× 80 0.4× 124 1.0× 53 0.5× 143 2.2× 11 508
Lisa Painter United States 6 55 0.3× 92 0.4× 79 0.6× 55 0.6× 31 0.5× 12 308
Om Prakash India 11 43 0.2× 145 0.7× 65 0.5× 107 1.1× 67 1.0× 42 468
Susan H. Gawel United States 9 44 0.2× 73 0.3× 33 0.3× 92 0.9× 81 1.3× 25 386
John H. Rogers United States 12 167 0.8× 53 0.2× 57 0.5× 50 0.5× 62 1.0× 31 476
Patumrat Sripan Thailand 12 85 0.4× 99 0.5× 51 0.4× 33 0.3× 85 1.3× 62 385
Eniola Obadina United States 9 84 0.4× 127 0.6× 13 0.1× 43 0.4× 41 0.6× 10 427
Jiraporn Srinakarin Thailand 9 58 0.3× 118 0.6× 29 0.2× 27 0.3× 50 0.8× 27 331
Stéphane Jouveshomme France 8 113 0.5× 92 0.4× 28 0.2× 425 4.3× 79 1.2× 22 642

Countries citing papers authored by V. Cohen

Since Specialization
Citations

This map shows the geographic impact of V. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Cohen more than expected).

Fields of papers citing papers by V. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Cohen. The network helps show where V. Cohen may publish in the future.

Co-authorship network of co-authors of V. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of V. Cohen. A scholar is included among the top collaborators of V. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Cohen. V. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ezeife, Doreen A., Eldon Spackman, Rosalyn A. Juergens, et al.. (2021). OA16.02 The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(10). S876–S876. 3 indexed citations
2.
Yang, Chengwu, et al.. (2021). What Factors Influence Dental Faculty’s Willingness to Treat Pregnant Women?. JDR Clinical & Translational Research. 7(4). 407–414. 2 indexed citations
3.
Laurie, Scott A., Jason Agulnik, Desirée Hao, et al.. (2020). 1195P The value of detecting resistance through liquid biopsy. Annals of Oncology. 31. S786–S787. 1 indexed citations
4.
Agulnik, Jason, Goulnar Kasymjanova, Carmela Pepe, et al.. (2020). Understanding Clinical Practice and Survival Outcomes in Patients with Unresectable Stage III Non-Small-Cell Lung Cancer in a Single Centre in Quebec. Current Oncology. 27(5). 459–466. 12 indexed citations
5.
Agulnik, Jason, Goulnar Kasymjanova, Pierre Fiset, et al.. (2019). The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma. Lung Cancer. 132. 36–38. 19 indexed citations
6.
Kasymjanova, Goulnar, R. Thomas Jagoe, Carmela Pepe, et al.. (2018). Does the Presence of Emphysema Increase the Risk of Radiation Pneumonitis in Lung Cancer Patients?. Current Oncology. 25(6). 610–614. 6 indexed citations
7.
Ali, Adnan, Sophie Camilleri‐Broët, V. Cohen, et al.. (2018). P2.01-04 Reducing Time to Molecular Diagnosis for Advanced NSCLC in the Context of a Reference Testing Center. Journal of Thoracic Oncology. 13(10). S666–S666. 1 indexed citations
8.
Agulnik, Jason, Goulnar Kasymjanova, V. Cohen, et al.. (2018). Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer. Annals of Oncology. 29(6). 1417–1422. 84 indexed citations
9.
Kasymjanova, Goulnar, Lama Sakr, Donna M. Small, et al.. (2018). P1.04-16 Comparison of Clinical Response to Checkpoint Inhibitors in Advanced NSCLC with High PD-L1 Expression Tested on Cytology Versus Biopsy Samples. Journal of Thoracic Oncology. 13(10). S531–S531. 4 indexed citations
10.
Agulnik, Jason, Goulnar Kasymjanova, Lama Sakr, et al.. (2018). MA09.09 EBUS-TBNA in Assessing PD-L1 Expression in NSCLC. Journal of Thoracic Oncology. 13(10). S387–S387. 1 indexed citations
11.
Kasymjanova, Goulnar, David Small, V. Cohen, et al.. (2017). Lung Cancer Care Trajectory at a Canadian Centre: An Evaluation of How Wait Times Affect Clinical Outcomes. Current Oncology. 24(5). 302–309. 33 indexed citations
12.
Agulnik, Jason, Goulnar Kasymjanova, Ansheng Wang, et al.. (2017). P2.02-040 Cytology Cell Block Is Suitable for Immunohistochemical Testing for PD-L1 in Lung Cancer. Journal of Thoracic Oncology. 12(11). S2113–S2113. 1 indexed citations
13.
Kayaniyil, Sheena, Joanna Y. Wilson, Paul Wheatley‐Price, et al.. (2016). Treatment Patterns and Survival in Patients with ALK-Positive Non-small-Cell Lung Cancer: A Canadian Retrospective Study. Current Oncology. 23(6). 589–597. 15 indexed citations
14.
15.
Kasymjanova, Goulnar, Trần Nam Thắng, R. Thomas Jagoe, et al.. (2013). The Potential Role for Acupuncture in Treating Symptoms in Patients with Lung Cancer: An Observational Longitudinal Study. Current Oncology. 20(3). 152–157. 24 indexed citations
16.
Sutton, Julian, et al.. (2012). A comparison of epidural and cerebrospinal fluid glucose in parturients at term: an observational study. International Journal of Obstetric Anesthesia. 21(3). 242–244. 4 indexed citations
17.
Sahebjam, Solmaz, Raquel Aloyz, Dragana Pilavdzic, et al.. (2011). Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score. British Journal of Cancer. 105(9). 1342–1345. 74 indexed citations
18.
Cohen, V., E. W. Powell, & Carol L. Lake. (2011). Failure of neuraxial anaesthesia in a patient with Velocardiofacial syndrome. International Journal of Obstetric Anesthesia. 20(3). 256–259. 3 indexed citations
19.
Agarwal, Surendra Kumar, Vera Hirsh, Jason Agulnik, et al.. (2010). A phase II study of gefitinib (G) versus carboplatin and gemcitabine (CG) in chemotherapy-naïve patients with advanced non-small cell lung cancer (NSCLC) and ECOG performance status (PS) 2.. Journal of Clinical Oncology. 28(15_suppl). e18090–e18090. 2 indexed citations
20.
Glezerman, Marek, V. Cohen, J. Shoham, et al.. (1988). PLACEBO-CONTROLLED TRIAL OF TOPICAL INTERFERON IN LABIAL AND GENITAL HERPES. The Lancet. 331(8578). 150–152. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Moeremans Breakdown of academic impact, for papers by Steve Shiboski Breakdown of academic impact, for papers by Lisa Painter Breakdown of academic impact, for papers by Om Prakash Breakdown of academic impact, for papers by Susan H. Gawel Breakdown of academic impact, for papers by John H. Rogers Breakdown of academic impact, for papers by Patumrat Sripan Breakdown of academic impact, for papers by Eniola Obadina Breakdown of academic impact, for papers by Jiraporn Srinakarin Breakdown of academic impact, for papers by Stéphane Jouveshomme
Rankless by CCL
2026